Pure red blood cell aplasia: patient management pitfalls in major ABO‐incompatible haematopoietic cell transplantation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pure red blood cell aplasia: patient management pitfalls in major ABO‐incompatible haematopoietic cell transplantation

Published:2021-04-12 Issue:4 Volume:193 Page:701-702
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br. J. Haematol.

Author:

Booth Garrett S.¹,Savani Bipin N.²³,Langston Amelia A.⁴

Affiliation:

1. The Department of Pathology, Microbiology and Immunology Vanderbilt University Medical Center Nashville TNUSA

2. The Department of Oncology Vanderbilt University Medical Center Nashville TNUSA

3. Tennessee Valley Veterans Affairs Hospital Nashville TNUSA

4. Department of Hematology and Medical Oncology Winship Cancer Institute of Emory University Atlanta GA USA

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.17465

Reference15 articles.

1. Treatment for pure red cell aplasia after major ABO‐incompatible allogeneic stem cell transplantation: a multicentre study

2. No post-transplant pure red cell aplasia development in 106 major ABO incompatible cord blood transplantation

3. Persistence of recipient plasma cells and anti-donor isohaemagglutinins in patients with delayed donor erythropoiesis after major ABO incompatible non-myeloablative haematopoietic cell transplantation

4. Isohemagglutinin titering performed on an automated solid‐phase and hemagglutinin‐based analyzer is comparable to results obtained by manual gel testing

5. Comparative Evaluation of Five Different Methods of Anti-ABO Antibody Titration: An Aid for ABO-Incompatible Organ Transplants

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pure red cell aplasia among ABO mismatched hematopoietic stem cell transplant recipients: a 13-years retrospective study and literature review;Frontiers in Oncology;2024-07-02

2. Immuno-Hematologic Complexity of ABO-Incompatible Allogeneic HSC Transplantation;Cells;2024-05-10

3. Daratumumab may be the most effective treatment for post-engraftment pure red cell aplasia due to persistent anti-donor isohemagglutinins after major ABO-mismatched allogeneic transplantation;Bone Marrow Transplantation;2021-10-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3